These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21536370)

  • 1. Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia.
    Wang Z; Olumi AF
    Differentiation; 2011; 82(4-5):261-71. PubMed ID: 21536370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factors and risk of benign prostatic hyperplasia.
    Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
    Prostate; 2002 Jul; 52(2):98-105. PubMed ID: 12111701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.
    Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J
    Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W; Zhang X; Mize GJ; Takayama TK
    Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.
    Li W; Wu CL; Febbo PG; Olumi AF
    Am J Pathol; 2007 Oct; 171(4):1189-98. PubMed ID: 17702894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-resistance and benign prostatic hyperplasia: the connection.
    Vikram A; Jena G; Ramarao P
    Eur J Pharmacol; 2010 Sep; 641(2-3):75-81. PubMed ID: 20553919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro.
    Han HJ; Kang CW; Park SH
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1172-9. PubMed ID: 17184497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interleukins, IGF and stem cells in BPH.
    McLaren ID; Jerde TJ; Bushman W
    Differentiation; 2011; 82(4-5):237-43. PubMed ID: 21864972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia.
    Nandeesha H; Koner BC; Dorairajan LN; Sen SK
    Clin Chim Acta; 2006 Aug; 370(1-2):89-93. PubMed ID: 16516184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IGF system in the neonatal ovine uterus.
    Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE
    Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.
    Mannowetz N; Würdinger R; Zippel A; Aumüller G; Wennemuth G
    Prostate; 2010 Sep; 70(12):1350-8. PubMed ID: 20623639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
    Wu JD; Haugk K; Woodke L; Nelson P; Coleman I; Plymate SR
    J Cell Biochem; 2006 Oct; 99(2):392-401. PubMed ID: 16639715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-Like Growth Factor (IGF) family and prostate cancer.
    Gennigens C; Menetrier-Caux C; Droz JP
    Crit Rev Oncol Hematol; 2006 May; 58(2):124-45. PubMed ID: 16387509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of hepatic IGFBP-1 production as a strategy for preventing benign prostatic hyperplasia.
    McCarty MF
    Med Hypotheses; 2001 Jan; 56(1):1-4. PubMed ID: 11133245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
    J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.
    Jiang M; Strand DW; Franco OE; Clark PE; Hayward SW
    Differentiation; 2011; 82(4-5):220-36. PubMed ID: 21645960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
    Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y
    J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.